Patent details

EP3535300 Title: ACTIVATABLE ANTI-CTLA-4 ANTIBODIES AND USES THEREOF

Basic Information

Publication number:
EP3535300
PCT Application Number:
US2017059740
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP178379178
PCT Publication Number:
WO2018085555
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ACTIVATABLE ANTI-CTLA-4 ANTIBODIES AND USES THEREOF
French Title of Invention:
ANTICORPS ANTI-CTLA-4 ACTIVABLES ET LEURS UTILISATIONS
German Title of Invention:
AKTIVIERBARE ANTI-CTLA-4-ANTIKÖRPER UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
02/11/2017
Grant date:
22/10/2025
EP Publication Date:
11/09/2019
PCT Publication Date:
11/05/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/10/2025
EP B1 Publication Date:
22/10/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
02/11/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/10/2025
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Name:
CytomX Therapeutics, Inc.
Address:
151 Oyster Point Boulevard Suite 400, South San Francisco, California 94080, United States (US)

Inventor

1

Name:
DESHPANDE, Shrikant
Address:
United States (US)

2

Name:
TIPTON, Kimberly Ann
Address:
United States (US)

3

Name:
WEST, James William
Address:
United States (US)

4

Name:
ENGELHARDT, John J.
Address:
United States (US)

Priority

Priority Number:
201662417212 P
Priority Date:
03/11/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61K 39/395; C12N 15/13; C12N 15/62; C07K 19/00; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202543
Publication date:
22/10/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages